Cephalon, Inc. (NASDAQ: CEPH) announced today that it has exercised its option to acquire Ception Therapeutics, Inc., following receipt of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE